Preclinical characterization of DEKAVIL (F8-IL10), a novel clinical-stage immunocytokine which inhibits the progression of collagen-induced arthritis

DEKAVIL (F8-IL10) 是一种新型临床阶段免疫细胞因子，可抑制胶原诱导性关节炎的进展，对其进行了临床前表征。